Amarin Corp Plc (AMRN)

[sharinky]

"It’s obvious AZN has significant interest in Amarin and its obvious Amarin is prepared to entertain interest, why else would JT know Vascepa RRR 38% in STRENGTH cohort... "

I just see this as Amarin being ready for future competition. All they had to do was look at the criteria for inclusion into STRENGTH and ask their data analysis group to run a detailed analysis on this subgroup. It shows that for a small pharma, they are on top of it. I think it really took the Citi analyst off guard. He was surprised by the number and that JT had it available.